(Q39554921)

13 September 2017

1 reference

title

Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (English)

1 reference

13 September 2017

1 reference

J M Henwood

1

1 reference

PubMed ID

3063494

13 September 2017

J P Monk

series ordinal

2

1 reference

13 September 2017

1 July 1988

1 reference

13 September 2017

1 reference

13 September 2017

36

1 reference

13 September 2017

1

1 reference

13 September 2017

32-66

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198836010-00004

13 September 2017

0 references

cites work

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents

1 reference

12 December 2020

Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia

1 reference

12 December 2020

Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations

1 reference

12 December 2020

Penetration of enoxacin into bronchial secretions

1 reference

12 December 2020

Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones

1 reference

12 December 2020

Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin

1 reference

12 December 2020

Enoxacin in the treatment of sexually transmitted diseases

1 reference

12 December 2020

A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

1 reference

12 December 2020

The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.

1 reference

12 December 2020

In vitro and in vivo antibacterial activity of AT-2266.

1 reference

12 December 2020

Quinolone/ureidopenicillin cross-resistance

1 reference

12 December 2020

[Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man]

1 reference

12 December 2020

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound

1 reference

12 December 2020

Nalidixic-acid-resistant Shigella dysenteriae I

1 reference

12 December 2020

Enoxacin concentration in human prostatic tissue after oral administration

1 reference

12 December 2020

Enoxacin treatment of urinary tract infections

1 reference

12 December 2020

The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin

1 reference

12 December 2020

Mode of Incomplete Cross-Resistance Among Pipemidic, Piromidic, and Nalidixic Acids

1 reference

12 December 2020

Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic

1 reference

12 December 2020

Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin

1 reference

12 December 2020

Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin

1 reference

12 December 2020

Quinolones: pharmacology

1 reference

12 December 2020

Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials.

1 reference

12 December 2020

Influence of various antibiotics on phagocytosis of Staphylococcus aureus by human polymorphonuclear leucocytes

1 reference

12 December 2020

Comparative in-vitro activity of five fluoroquinolones against mycobacteria

1 reference

12 December 2020

In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies

1 reference

12 December 2020

Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile

1 reference

12 December 2020

An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.

1 reference

12 December 2020

In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam

1 reference

12 December 2020

Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.

1 reference

12 December 2020

In-vitro activity of newer quinolones against aerobic bacteria.

1 reference

12 December 2020

In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Effect of food on enoxacin absorption

1 reference

12 December 2020

Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.

1 reference

12 December 2020

Urinary enoxacin concentration and excretion after a single dose

1 reference

12 December 2020

Influence of various antibiotics on superoxide generation by normal human neutrophils

1 reference

12 December 2020

Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates

1 reference

12 December 2020

The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi

1 reference

12 December 2020

Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens

1 reference

12 December 2020

Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days

1 reference

12 December 2020

Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males

1 reference

12 December 2020

4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro

1 reference

12 December 2020

Enoxacin in lower respiratory tract infections.

1 reference

12 December 2020

The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.

1 reference

12 December 2020

Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis

1 reference

12 December 2020

Enoxacin distribution in human tissues after multiple oral administration

1 reference

12 December 2020

Comparative effects of enoxacin and norfloxacin on human colonic microflora

1 reference

12 December 2020

Enoxacin treatment of urinary tract infections in elderly patients

1 reference

12 December 2020

Comparative studies of enoxacin and amoxicillin for acute uncomplicated cystitis in women

1 reference

12 December 2020

Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects

1 reference

12 December 2020

Enoxacin-induced alteration of susceptibility of pneumococci and Pseudomonas to phagocytosis by human polymorphonuclear leukocytes.

1 reference

12 December 2020

Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.

1 reference

12 December 2020

Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile

1 reference

12 December 2020

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

1 reference

12 December 2020

Pharmacokinetics of AT-2266 Administered Orally to Mice, Rats, Dogs, and Monkeys

1 reference

12 December 2020

In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.

1 reference

12 December 2020

In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis

1 reference

12 December 2020

The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers

1 reference

12 December 2020

Enoxacin for the treatment of urinary tract infection.

1 reference

12 December 2020

Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates

1 reference

12 December 2020

Efficacy of enoxacin in the treatment of bacterial infections of the skin with regards to photosensitization

1 reference

12 December 2020

The influence of quinolone derivatives on theophylline clearance

1 reference

12 December 2020

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.

1 reference

12 December 2020

In-vitro activity of enoxacin against gonococcal isolates in comparison with that of five other antibiotics

1 reference

12 December 2020

Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study

1 reference

12 December 2020

Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides

1 reference

12 December 2020

High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva

1 reference

12 December 2020

Elimination of enoxacin in renal disease

1 reference

12 December 2020

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

1 reference

12 December 2020

Gyrase-inhibitors impair caffeine elimination in man

1 reference

12 December 2020

Oral enoxacin used to cure spinal osteomyelitis due to aminoglycoside-resistant Pseudomonas aeruginosa.

1 reference

12 December 2020

Convulsions related to enoxacin

1 reference

12 December 2020

Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers

1 reference

12 December 2020

Double blind, randomised trial comparing single dose enoxacin and trimethoprim for treatment of bacterial cystitis

1 reference

12 December 2020

Enoxacin decreases the clearance of theophylline in man.

1 reference

12 December 2020

Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.

1 reference

12 December 2020

In vitro activity of enoxacin compared with norfloxacin and amikacin.

1 reference

12 December 2020

Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents.

1 reference

12 December 2020

Enoxacin: worldwide in-vitro activity against 22451 clinical isolates

1 reference

12 December 2020

Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations.

1 reference

12 December 2020

Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).

1 reference

12 December 2020

Intravenous enoxacin for the treatment of acute pyelonephritis: pharmacokinetic and clinical study

1 reference

12 December 2020

Clinical pharmacokinetics of the newer antibacterial 4-quinolones

1 reference

12 December 2020

A comparison of enoxacin and co-trimoxazole in the treatment of patients with complicated urinary tract infections

1 reference

12 December 2020

In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents

1 reference

12 December 2020

Enoxacin in the treatment of lower respiratory tract infections

1 reference

12 December 2020

In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus

1 reference

12 December 2020

Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis

1 reference

12 December 2020

Enoxacin in the treatment of complicated urinary tract infections

1 reference

12 December 2020

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

1 reference

12 December 2020

The effect of age on the pharmacokinetics of enoxacin

1 reference

12 December 2020

Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.

1 reference

12 December 2020

Pharmacokinetics and tolerance of enoxacin in healthy volunteers administered at a dosage of 400 mg twice daily for 14 days

1 reference

12 December 2020

The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of enoxacin and norfloxacin

1 reference

12 December 2020

Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis

1 reference

12 December 2020

In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria

1 reference

12 December 2020

Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli

1 reference

12 December 2020

The quinolones in chronic bronchitis

1 reference

12 December 2020

Penetration of enoxacin into human bronchial mucosa

1 reference

12 December 2020

Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.

1 reference

12 December 2020

Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa

1 reference

12 December 2020

An evaluation of pelvic tissue concentrations after oral administration of enoxacin

1 reference

12 December 2020

Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia

1 reference

12 December 2020

Diffusion of enoxacin into the cerebrospinal fluid in dogs with healthy meninges and with experimental meningitis.

1 reference

12 December 2020

The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms

1 reference

12 December 2020

In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates

1 reference

12 December 2020

Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli

1 reference

12 December 2020

[Results of treatment of bacterial inflammation of the skin with enoxacin]

1 reference

12 December 2020

Enoxacin in the treatment of bronchopulmonary infections

1 reference

12 December 2020

Comparative in vitro studies with 4-quinolone antimicrobials

1 reference

12 December 2020

In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections

1 reference

12 December 2020

Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections

1 reference

12 December 2020

Activities of new quinoline derivatives against genital pathogens

1 reference

12 December 2020

Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains

1 reference

12 December 2020

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid

1 reference

12 December 2020

In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid

1 reference

12 December 2020

Treatment of chancroid with enoxacin

1 reference

12 December 2020

Comparative in-vitro activity of enoxacin against penicillinase- and non-penicillinase-producing Neisseria gonorrhoeae.

1 reference

12 December 2020

Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin

1 reference

12 December 2020

Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

1 reference

12 December 2020

In-vitro sensitivity of legionellas, meningococci and mycoplasmas to ciprofloxacin and enoxacin

1 reference

12 December 2020

In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin

1 reference

12 December 2020

The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin

1 reference

12 December 2020

10.2165/00003495-198836010-00004

Identifiers

DOI

1 reference

PubMed ID

3063494

Dimensions Publication ID

13 September 2017

0 references

1 reference

PubMed ID

3063494